Predictive Biomarker for Endoscopic Therapy in Chronic Pancreatitis

Part of paid clinical trials in New York, New York.

Sponsor
NYU Langone Health
Study ID
NCT06267365
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This is an observational prospective study to develop predictive biomarkers for pain response in participants with chronic pancreatitis scheduled for endoscopic therapy. Participants will undergo baseline assessments including electroencephalography (EEG), quantitative sensory testing (QST), and psychosocial questionnaires. Response to endoscopic therapy will be assessed at approximately 3, 6, 12 and 18 months post-procedure using questionnaires.

Key Dates

Start date
Nov 27, 2023
Status verified
Dec 2025
Primary completion
Mar 1, 2027
Completion
Jun 1, 2028

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: Adult Patients with Painful Chronic Pancreatitis
    Participants with chronic pancreatitis scheduled for endoscopic therapy will undergo baseline assessments including EEG, quantitative sensory testing, and psychosocial questionnaires. Follow-up questionnaires will be completed at approximately 3, 6, 12 and 18 months post-procedure.

Primary Outcome Measure

Change from Baseline in Brief Pain Inventory (BPI) Score at Month 3 Post-Operation [ Time Frame: Baseline, Month 3 Post-Operation ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
NYU Langone HealthNew YorkNew York10016-

Find similar trials in New York, NY

By research site
NYU Langone Health· New York, NY

Related Studies